Csl Ltd has released a press release.
Update on Acquisition of Vifor Pharma
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from CSL
- Statutory Accounts for Half Year Ended 31 December 2021
- CSL completes A$750 million Share Purchase Plan
- Successful Completion of A$6.3B Institutional Placement
- Investor Presentation CSL Swiss Tender Acquisition of Vifor
- Swiss tender offer to acquire 100% of vifor pharma ltd
Later from CSL
- CSL successfully issues bonds in US debt markets
- Vifor update ASX Announcement for lodgement
- Finalisation of Vifor Pharma Acquisition
- CSL Vifor Market Briefing
- CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology
Follow CSL into a list and get an email when it puts out news.
Follow CSL